Robinswood Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136K Buy
1,059
+7
+0.7% +$819 0.04% 94
2026
Q1
$127K Buy
1,052
+7
+0.7% +$808 0.04% 95
2025
Q4
$110K Sell
1,045
-299
-22% -$28.1K 0.04% 99
2025
Q3
$113K Buy
1,344
+1
+0.1% +$82 0.04% 97
2025
Q2
$106K Buy
1,343
+549
+69% +$43.6K 0.04% 101
2025
Q1
$71.3K Buy
794
+578
+268% +$54K 0.03% 110
2024
Q4
$21.6K Sell
216
-98
-31% -$10.1K 0.01% 161
2024
Q3
$35.7K Buy
314
+60
+24% +$7.13K 0.01% 145
2024
Q2
$31.5K Buy
254
+60
+31% +$7.73K 0.01% 149
2024
Q1
$25.5K Hold
194
0.01% 126
2023
Q4
$21.2K Hold
194
0.01% 128
2023
Q3
$20K Hold
194
0.01% 129
2023
Q2
$22.5K Buy
+194
New +$22K 0.01% 108

Other funds holding MRK

Robinswood Financial's MRK Position: Q2 2026 in Review

Robinswood Financial increased its Merck (MRK) stake by 0.67% in Q2 2026, buying an estimated $819 and bringing the position to 1,059 shares worth $136K. The position accounts for 0.04% of the portfolio, ranked #94.

Robinswood Financial first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Robinswood Financial held 1,059 shares of Merck worth $136K as of Q2 2026.
  • Robinswood Financial bought 7 Merck shares in Q2 2026, an estimated $819.
  • Merck made up 0.04% of Robinswood Financial's portfolio in Q2 2026, its #94 holding.
  • Robinswood Financial first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.